4 Promising Stocks From a Challenging Outpatient Home Health Industry

4 Promising Stocks From a Challenging Outpatient Home Health Industry

The pandemic altered the nature and dynamics of the healthcare industry. The Zacks Medical – Outpatient and Home Healthcare industry bore the brunt of lower outpatient clinic visits and struggled to provide quality care with respect to home healthcare due to the risk of exposure to the virus as well as the record level of staffing shortages. In recent times, although the severity of the infection has declined, there has been a circulation of a mixture of respiratory viruses per a recently-published data published by the Centers for Disease Control and Prevention. Apart from the respiratory ailments, the U.S. healthcare system is also currently being bothered by the recent increasing threat of spread of the antimicrobial resistant fungus — Candida auris (C. auris) — in healthcare facilities. Another concern plaguing the U.S. healthcare system is the persistent cost inflation and supply-chain constraints. These are consistently pushing up the operating costs of the healthcare industry, thereby lowering the margins of industry players.

On a positive note, rising dependence on telehealth and artificial intelligence (AI) is likely to help the industry thrive in the near term. Chemed Corporation CHE, Addus HomeCare Corporation ADUS, RadNet, Inc. RDNT and The Pennant Group, Inc. PNTG are likely to gain from the prospects.

Industry Description

The industry comprises companies that offer ambulatory care in an outpatient setting or at home. These companies use advanced medical technologies for diagnosis, observation, consultation, treatment and rehabilitation services. The industry participants also include operators of HMO medical centers, kidney dialysis centers, freestanding ambulatory surgical units, emergency centers and other outpatient care centers. Some of the companies in this space have been at the forefront of the COVID-19 pandemic response since 2020 by expanding access to laboratory insights to enable people to lead healthier and safer lives through both molecular diagnostic and antibody serology tests. These tests help in the diagnosis of COVID-19 and the identification of immune response to the virus.

Major Trends Shaping the Future of the Outpatient and Home Healthcare Industry

Cost Effectiveness: The primary advantage of outpatient clinics is cost-effectiveness. Outpatient medical care clinics do not retain patients for long hours (overnight) or charge exorbitantly. Notably, modern-day outpatient clinics offer a broad spectrum of treatment and diagnostic options and even minor surgical procedures. Financial incentives like health plans and government program payment policies supporting services in lower-cost care settings have also been driving outpatient care. In fact, this is the primary reason why middle-class Americans, making up more than 62{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the total population, prefer outpatient clinic visits.

Participating in Alternative Payment Models: It only seems reasonable for outpatient clinics to shift from fee-for-service (FFS) to alternative payment models (APM) with shared savings, risk, bundled payments or population-based payments. With value-based models of care steadily emerging as the future of healthcare, this shift is an ongoing parallel trend. FFS will be crucial to care organizations as a benchmark by which providers can assess alternative payment models. By obtaining the payment schedule from payers and comparing it to the organization’s FFS reimbursements from the same payer, providers can ascertain APM that would be financially the most advantageous to its operation.

AI’s Dominant Role: AI has been a roaring success in healthcare. It is no wonder that it has taken the outpatient and home healthcare space by storm. Outpatient companies prefer bots and automated techniques for managing health information. With the help of AI, hospitals have been achieving better outcomes, with patients receiving more efficient and personalized care. The outpatient industry has been generating huge profits from Electronic Health Records, Revenue Cycle Management, eLabs and ePrescriptions.

In recent times, healthcare facilities are experimenting with software designed to help doctors automatically generate notes from conversations with patients. Microsoft, in its official blog, has confirmed that it (along with Nuance) is introducing a solution — Dragon Ambient eXperience (DAX) Express. It is an automated clinical documentation application integrated into the workflow that combines proven conversational and ambient AI with advanced reasoning and natural language capabilities of OpenAI’s GPT-4.

Increased Dependence on Telehealth: The pandemic resulted in a decline in outpatient clinic visits. Home healthcare providers struggled to offer quality care due to the risk of exposure to the virus. Though the impact of the pandemic has been far-reaching, it has accelerated healthcare innovation. Visits to outpatient clinics have been witnessing a noticeable rebound, with the majority of people being vaccinated. But there are patients who want to be cautious and are resorting to telehealth. Meanwhile, home healthcare can gain from the benefits provided by Medicare (and several other payers) that comprises a broad range of services that can be delivered in a patient’s home, including post-operative and chronic wound care, rehabilitation, and physical therapy. These services serve as lifelines for vulnerable patients, including the Medicare population, suffering from complications arising from COVID-19. Moreover, home healthcare has seen a surge in the utilization of the telehealth platform in response to the pandemic.

A notable trend that has been emerging in this respect is the increasing popularity of the hybrid mode of treatment. As there are certain chronic health conditions, which cannot be identified over a telephone or video call, patients are embracing the hybrid mode of seeking treatments from their physicians in these cases.

Prominent Role of Remote Patient Monitoring: Remote patient monitoring (RPM) has been gradually gaining ground since the pandemic. During that phase, it was difficult to keep a watch on non-COVID patients in the hospital care setting as hospital capacities were brimming with COVID-19 patients. Thus, non-critical patients were increasingly being provided with healthcare in the comfort of their homes while being remotely monitored by their care providers. Even with the return to normalcy, patients are increasingly preferring to be monitored from their homes via RPM devices. This is also boosting home healthcare services as vulnerable patients can be safely and adequately cared from the home setting instead of hospital settings, where the risk of COVID-19 or other infections persists.

Zacks Industry Rank

The Zacks Medical – Outpatient and Home Healthcare industry falls within the broader Zacks Medical sector. It carries a Zacks Industry Rank #156, which places it in the bottom 38{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of nearly 250 Zacks industries.

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates bleak near-term prospects. Our research shows that the top 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the Zacks-ranked industries outperforms the bottom 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} by a factor of more than 2 to 1.

Before we present a few outpatient home health stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock-market performance and valuation picture.

Industry’s Stock Market Performance

The industry has underperformed both its sector and the Zacks S&P 500 composite in the past year.

The industry has declined 22.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over this period compared with the S&P 500’s decline of 13.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The broader sector has declined 17.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in the same time frame.

One Year Price Performance

Zacks Investment Research
Image Source: Zacks Investment Research

Industry’s Current Valuation

On the basis of the forward 12-month price-to-earnings (P/E), which is commonly used for valuing medical stocks, the industry is currently trading at 27.5X compared with the S&P 500’s 17.7X and the sector’s 21.6X.

Over the last five years, the industry has traded as high as 31.5X and as low as 16.8X, with the median being at 21.7X, as the charts below show.

Price-to-Earnings Forward Twelve Months (F12M)

Zacks Investment Research
Image Source: Zacks Investment Research

Price-to-Earnings Forward Twelve Months (F12M)

Zacks Investment Research
Image Source: Zacks Investment Research

4 Promising Outpatient and Home Healthcare Stocks

Chemed: The company operates through two wholly owned subsidiaries — VITAS Healthcare Corporation (a renowned provider of end-of-life care) and Roto-Rooter (a well-known commercial and residential plumbing and drain cleaning services provider). Chemed announced its fourth-quarter 2022 results last month, wherein it registered an uptick in its overall revenues. It also recorded robust reported sales in its Roto-Rooter business, wherein the total Roto-Rooter branch commercial revenues improved 8.7{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} from last year on a 5.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} increase in drain cleaning revenues, a 13.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} rise in commercial plumbing, 5.1{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} growth in excavation revenues and a 27.3{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} hike in commercial water restoration revenues. CHE carries a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Price and Consensus: CHE

Zacks Investment Research
Image Source: Zacks Investment Research

For this company, the Zacks Consensus Estimate for 2023 revenues suggests growth of 4.7{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The same for earnings indicates an increase of 5.6{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s return on equity (ROE) of 41.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} compares favorably with the industry’s 6.4{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

Addus HomeCare: Its services and operating model address a number of crucial needs across the healthcare continuum. Last month, Addus HomeCare announced its fourth-quarter 2022 results, where it registered a solid uptick in its net service revenues. Management confirmed that its personal care revenues (accounting for 74.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of overall revenue) improved year over year on a same-store basis, reflecting steady volume growth trends. Home health revenues, which included the operations of Armada Home Health and Summit Home Health acquired in 2021, and the addition of Apple Home Healthcare operations effective Oct 1, 2022, were also up year over year on a same-store basis. ADUS carries a Zacks Rank of 2.

Price and Consensus: ADUS

Zacks Investment Research
Image Source: Zacks Investment Research

For this company, the Zacks Consensus Estimate for 2023 revenues suggests growth of 8.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The same for earnings indicates an increase of 9.4{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s ROE of 8.6{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} compares favorably with the industry’s 6.4{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

RadNet: It is a renowned provider of fixed-site outpatient diagnostic imaging services through a network of owned and/or operated outpatient imaging centers. Last month, RadNet announced its fourth-quarter 2022 results, where it registered a solid uptick in its net revenues, both including and excluding revenues from the AI reporting segment. The company’s aggregate procedural volumes and same-center procedural volumes also increased year over year in the reported quarter. On the back of its performance in the fourth quarter of 2022, management is optimistic about its financial position and operating model, which has presented RadNet with targeted opportunities to expand its business, particularly through the construction of new centers to meet growing demand and utilization in strategic markets. RDNT carries a Zacks Rank of 2.

Price and Consensus: RDNT

Zacks Investment Research
Image Source: Zacks Investment Research

For this Los Angeles, CA-based company, the Zacks Consensus Estimate for 2023 revenues suggests growth of 9.6{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The same for earnings indicates an increase of 70{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s P/CF ratio of 6.6 compares favorably with the industry’s 9.4.

The Pennant Group: It is the parent company of the Pennant group of affiliated home health, hospice and senior living companies. This month, The Pennant Group completed the acquisition of operations of Robins Landing at New Berlin, WI and Robins Landing at Brookfield, WI. Last month, it reported its fourth-quarter 2022 results, where it witnessed solid improvement in its overall top line. Its Home Health and Hospice Services segment recorded a robust uptick in revenues, whereas the company also recorded strength in its total home health admissions and total Medicare home health admissions. The uptick in total hospice admissions, Senior Living Services segment and Same store Senior Living Services segment for the fourth quarter was also impressive. PNTG carries a Zacks Rank of 2.

Price and Consensus: PNTG

Zacks Investment Research
Image Source: Zacks Investment Research

For this Eagle, ID-based company, the Zacks Consensus Estimate for 2023 revenues suggests growth of 8.4{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The same for earnings indicates an increase of 24.6{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s ROE of 12.4{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} compares favorably with the industry’s 6.4{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

Is THIS the Ultimate New Clean Energy Source? (4 Ways to Profit)

The world is increasingly focused on eliminating fossil fuels and ramping up use of renewable, clean energy sources. Hydrogen fuel cells, powered by the most abundant substance in the universe, could provide an unlimited amount of ultra-clean energy for multiple industries. 

Our urgent special report reveals 4 hydrogen stocks primed for big gains – plus our other top clean energy stocks.  

See Stocks Now

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Chemed Corporation (CHE) : Free Stock Analysis Report

Addus HomeCare Corporation (ADUS) : Free Stock Analysis Report

RadNet, Inc. (RDNT) : Free Stock Analysis Report

The Pennant Group, Inc. (PNTG) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

4 Retail Home Furnishing Stocks to Watch in a Challenging Industry

4 Promising Stocks From a Challenging Outpatient Home Health Industry

Soft demand conditions, given the housing market slowdown, continued investments in e-commerce, supply-chain bottlenecks and higher raw material costs in the home furnishing market are overriding efficient cost management and persistent focus on product innovation. While efforts are being made to redesign the supply-chain network and rationalize product offerings, investments in merchandising of brands and digital marketing may hurt somewhat. However, Zacks Retail-Home Furnishings industry players, such as Williams-Sonoma, Inc. WSM, Fortune Brands Innovations, Inc. FBIN, Tempur Sealy International, Inc. TPX and Ethan Allen Interiors Inc. (ETD), are looking to overcome the challenges.

Industry Description

The Zacks Retail-Home Furnishings industry comprises retailers offering home furnishing products under various categories. The merchandise assortment includes furniture, garden accessories, framed art, lighting, mirrors, candles, tableware, lamps, picture frames, bathware, accent rugs, artificial floral products, and child and teen furnishing. The industry players also develop, manufacture, market and distribute bedding products. The companies provide home and security products for residential home repair, remodeling, new construction, and security applications. They are involved in manufacturing, assembling, and selling faucets, accessories, kitchen sinks, and waste disposal.

3 Trends Shaping the Future of the Retail-Home Furnishings Industry

Soft Demand: The industry has been suffering from an uncertain macro environment, continued softeness in business trends as a result of the ongoing weakness in the housing market and the Federal Reserve’s series of interest rate hikes. Higher mortgage rates are taking a toll on the housing sector and hence on the furnishing market.

Supply-Chain Issues, Inflation, Stiff Competition & Labor Expenses: Industry players have been grappling with supply-chain bottlenecks. Due to supply issues across the world, these companies have been witnessing some inventory delays, product shortages and manufacturing delays. Accelerating raw material and freight costs (including e-commerce shipping) as well as higher employment-related expenses have been putting pressure on the companies’ margins.

Meanwhile, the home furnishings industry is highly competitive, with interior design trade and specialty stores, antique dealers, national and regional home furnishing retailers as well as department stores giving a hard time. Online retailers focused on home furnishing also pose a threat. Competitive product pricing has been eating into margins. Even though sales-building initiatives of the industry participants have been reaping positive results, these involve high costs.

Strong Digital Platform, Product Reinvention & Marketing Moves: Optimization of the supply chain and improvement in e-commerce channels are expected to drive the top line. In fact, e-commerce rescued the retail sector amid pandemic-induced uncertainties. This digital platform will continue to play a major role as people find it more comfortable and safer to shop online. Product innovation plays a key role in market share gain in this industry. Companies aim to come up with products and collaborate with celebrated brands as well as designers to maintain exclusivity. Also, customer experience is being enhanced by innovative marketing techniques, with an emphasis on digital marketing, better merchandising, store remodeling and loyalty programs.

Zacks Industry Rank Indicates Dull Prospects

The Zacks Retail-Home Furnishings industry is a seven-stock group within the broader Zacks Retail-Wholesale sector. The industry currently carries a Zacks Industry Rank #197, which places it in the bottom 22{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of more than 250 Zacks industries.

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates bleak near-term prospects. Our research shows that the top 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the Zacks-ranked industries outperform the bottom 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} by a factor of more than 2 to 1.

The industry’s positioning in the bottom 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the Zacks-ranked industries is a result of a dull earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are gradually losing confidence in this group’s bottom-line growth potential. Since December 2022, the industry’s earnings estimates for 2023 and 2024 have been revised 2.7{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} and 8.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} downward, respectively.

Despite the industry’s dim near-term view, we will present a few stocks that one may consider adding to the portfolio. Before that, it’s worth taking a look at the industry’s shareholder returns and current valuation.

Industry Outperforms Sector, Lags S&P 500

The Zacks Retail-Home Furnishings industry has outperformed the broader Zacks Retail-Wholesale sector but lagged the Zacks S&P 500 composite over the past year.

The industry has lost 5.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} compared with the S&P 500’s 5.3{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} decline. The broader sector has declined 9.7{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over this period.

One-Year Price Performance

Industry’s Current Valuation

On the basis of the forward 12-month price-to-earnings ratio, which is commonly used for valuing retail home furnishing stocks, the industry is currently trading at 11.01 compared with the S&P 500’s 18.2 and the sector’s 21.9.

Over the last five years, the industry has traded as high as 19.43X and as low as 7.09X, with the median being 14.05X, as the chart below shows.

Industry’s P/E Ratio (Forward 12-Month) Versus S&P 500

4 Retail-Home Furnishings Stocks to Watch

We have highlighted four stocks that currently carry a Zacks Rank #3 (Hold) and have been capitalizing on fundamental strengths. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Ethan Allen Interiors Inc.: This Danbury, CT-based company engages in interior design, and manufacture and retail of home furnishings. Its wide array of offerings, a strong network of retail design centers and focus on interior design services as well as technological enhancement have been benefiting the company. It remains well-positioned for fiscal 2023 with its product offerings and the advantage of vertical integration, including its North American manufacturing, interior design-focused retail network, a strong logistics network and a healthy balance sheet to maximize opportunities during the year.

ETD’s shares have gained 20.7{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over the past year, outperforming the industry. Earnings estimates for fiscal 2023 have increased 7.1{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} to $3.79 per share over the past 60 days. This depicts analysts’ optimism over the company’s growth prospects.

Price and Consensus: ETD

Tempur Sealy International: Headquartered in Lexington, KY, this company is involved in the development, manufacturing and marketing of bedding products. Strong industry demand, its worldwide leadership position in the industry and the omni-channel distribution strategy’s success have been boosting Tempur’s presence. Despite challenging macro conditions, the company has been investing in industry-leading product innovation and advertising spend, expanding manufacturing capacity, driving omni-channel expansion worldwide, and working on a balanced capital allocation strategy. For 2023, the company’s brand, products, and omnichannel initiatives will likely drive growth.

The TPX stock has gained 47.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over the past year, outperforming the industry. Earnings estimates for 2023 have increased to $2.70 per share from $2.63 over the past 60 days. The company carries a Zacks Rank #3 and has an expected earnings growth rate of 3.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} for 2023.

Price and Consensus: TPX

 

Fortune Brands Innovations: Based in Deerfield, IL, this company provides home and security products for residential home repair, remodeling, new construction, and security applications in the United States and internationally. In the ongoing challenging economic conditions, the company has been focusing on an alteration in cost structure, proficient production planning, protecting margins and improving cash generation in 2023. The company has rebranded its entire company, with a business focused on driving accelerated growth in categories through brand and innovation. It has reorganized the company from a decentralized structure with separate businesses to an aligned operating model that prioritizes activities that are key to brand, innovation and channel. These transformative changes will enable the company to drive growth in the future.

Although the FBIN stock has declined 22.7{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over the past year, it carries an impressive VGM Score of B. This helps to identify stocks with the most attractive value, growth and momentum. This company surpassed earnings estimates in all of the trailing four quarters, the average being 6.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

Price and Consensus: FBIN

Williams-Sonoma: This is a San Francisco, CA-based multi-channel specialty retailer. The company has been benefiting from its focus on digital initiatives, higher e-commerce penetration and product introductions. In addition to the continued enhancement of the e-commerce channel, optimization of the supply chain and disciplined cost control are expected to drive growth.

Although the WSM stock has declined 13.1{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over the past year, it carries an impressive VGM Score of B. This home furnishing provider surpassed earnings estimates in three of the trailing four quarters, the average being 9.6{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

Price and Consensus: WSM

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} or more in 2021. Previous recommendations have soared +143.0{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}, +175.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}, +498.3{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} and +673.0{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Williams-Sonoma, Inc. (WSM) : Free Stock Analysis Report

Tempur Sealy International, Inc. (TPX) : Free Stock Analysis Report

Ethan Allen Interiors Inc. (ETD) : Free Stock Analysis Report

Fortune Brands Innovations, Inc. (FBIN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

4 Stocks to Watch Amid a Challenging Outpatient Home Health Industry

4 Promising Stocks From a Challenging Outpatient Home Health Industry

The pandemic altered the nature and dynamics of the healthcare industry. The Zacks Medical – Outpatient and Home Healthcare industry bore the brunt of lower outpatient clinic visits and struggled to provide quality care with respect to home healthcare due to the risk of exposure to the virus as well as the record level of staffing shortages. The decline in the severity of the pandemic was followed by the mass opening up of the economy. However, risks related to the emergence of several subvariants of Omicron, including XBB and BQ.1.1, loom large on the U.S. MedTech sector. On a positive note, rising dependence on telehealth and artificial intelligence (AI) is likely to help the industry thrive in the near term. Option Care Health, Inc. OPCH, LifeStance Health Group, Inc. LFST, Addus HomeCare Corporation ADUS and The Pennant Group, Inc. PNTG are likely to gain from the prospects.

Industry Description

The industry comprises companies that offer ambulatory care in an outpatient setting or at home. These companies use advanced medical technologies for diagnosis, observation, consultation, treatment and rehabilitation services. The industry participants also include operators of HMO medical centers, kidney dialysis centers, freestanding ambulatory surgical units, emergency centers and other outpatient care centers. Some of the companies in this space have been at the forefront of the COVID-19 pandemic response since 2020 by expanding access to laboratory insights to enable people to lead healthier and safer lives through both molecular diagnostic and antibody serology tests, which help in the diagnosis of COVID-19 and the identification of immune response to the virus.

Major Trends Shaping the Future of the Outpatient and Home Healthcare Industry

Cost Effectiveness: The primary advantage of outpatient clinics is cost-effectiveness. Outpatient medical care clinics do not retain patients for long hours (overnight) or charge exorbitantly. Notably, modern-day outpatient clinics offer a broad spectrum of treatment and diagnostic options and even minor surgical procedures. Financial incentives like health plans and government program payment policies supporting services in lower-cost care settings have also been driving outpatient care. In fact, this is the primary reason why middle-class Americans, making up more than 62{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the total population, prefer outpatient clinic visits.

Participating in Alternative Payment Models: It only seems reasonable for outpatient clinics to shift from fee-for-service (FFS) to alternative payment models (APM) with shared savings, risk, bundled payments or population-based payments. With value-based models of care steadily emerging as the future of healthcare, this shift is an ongoing parallel trend. FFS will be crucial to care organizations as a benchmark by which providers can assess alternative payment models. By obtaining the payment schedule from payers and comparing it to the organization’s FFS reimbursements from the same payer, providers can ascertain APM that would be financially the most advantageous to its operation.

AI’s Dominant Role: AI has been a roaring success in healthcare. It’s no wonder that it has taken the outpatient and home healthcare space by storm. Outpatient companies prefer bots and automated techniques for managing health information. With the help of AI, hospitals have been achieving better outcomes, with patients receiving more efficient and personalized care. The outpatient industry has been generating huge profits from Electronic Health Records, Revenue Cycle Management, eLabs and ePrescriptions.

Increased Dependence on Telehealth: The pandemic resulted in a decline in outpatient clinic visits. Home healthcare providers struggled to offer quality care due to the risk of exposure to the virus. Though the impact of the pandemic has been far-reaching, it has accelerated healthcare innovation. Visits to outpatient clinics have been witnessing a noticeable rebound, with the majority of people being vaccinated. But there are patients who want to be cautious and are resorting to telehealth. Meanwhile, home healthcare can gain from the benefits provided by Medicare (and several other payers) that comprise a broad range of services that can be delivered in a patient’s home, including post-operative and chronic wound care, rehabilitation, and physical therapy. These services serve as lifelines for vulnerable patients, including the Medicare population, who can suffer from complications arising from COVID-19. Moreover, home healthcare has seen a surge in the utilization of the telehealth platform in response to the pandemic.

A notable trend that has been emerging in this respect is the increasing popularity of the hybrid mode of treatment. As there are certain chronic health conditions, which cannot be identified over a telephone or video call, patients are embracing the hybrid mode of seeking treatments from their physicians in those cases.

Prominent Role of Remote Patient Monitoring: Remote patient monitoring (RPM) has been gradually gaining ground since the pandemic. During that phase, it was difficult to keep a watch on non-COVID patients in the hospital care setting as hospital capacities were brimming with COVID-19 patients. Thus, non-critical patients were increasingly being provided with healthcare in the comfort of their homes while being remotely monitored by their care providers. Even with the gradual return to normalcy, patients are increasingly preferring to be monitored from their homes via RPM devices. This is also boosting home healthcare services as vulnerable patients can be safely and adequately cared from the home setting instead of hospital settings, where the risk of COVID-19 or other infections persists.

Zacks Industry Rank

The Zacks Medical – Outpatient and Home Healthcare industry falls within the broader Zacks Medical sector. It carries a Zacks Industry Rank #210, which places it in the bottom 15{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of nearly 250 Zacks industries.

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates bleak near-term prospects. Our research shows that the top 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the Zacks-ranked industries outperforms the bottom 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} by a factor of more than 2 to 1.

Before we present a few outpatient home health stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock-market performance and valuation picture.

Industry’s Stock Market Performance

The industry has underperformed both its sector and the Zacks S&P 500 composite in the past year.

The industry has declined 32.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over this period compared with the S&P 500’s decline of 22.3{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The broader sector has declined 20.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in the same time frame.

One Year Price Performance

Zacks Investment Research
Image Source: Zacks Investment Research

Industry’s Current Valuation

On the basis of the forward 12-month price-to-earnings (P/E), which is commonly used for valuing medical stocks, the industry is currently trading at 26.6X compared with the S&P 500’s 17.1X and the sector’s 22.5X.

Over the last five years, the industry has traded as high as 31.5X and as low as 16.8X, with the median being at 21X, as the charts below show.

Price-to-Earnings Forward Twelve Months (F12M)

Zacks Investment Research
Image Source: Zacks Investment Research

Price-to-Earnings Forward Twelve Months (F12M)

Zacks Investment Research
Image Source: Zacks Investment Research

4 Bankable Outpatient and Home Healthcare Stocks

LifeStance Health Group: LifeStance Health Group is a renowned provider of outpatient mental health care. The company announced its third-quarter 2022 results last month, wherein it registered a solid uptick in its overall revenues. It also recorded a robust improvement in its total clinicians in the reported quarter. Management is currently focusing on continuing its shift to organic growth, investing in strategic initiatives to build scalable infrastructure and driving operating leverage and profitability. LFST carries a Zacks Rank of 3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Price and Consensus: LFST

Zacks Investment Research
Image Source: Zacks Investment Research

For this Scottsdale, AZ-based company, the Zacks Consensus Estimate for 2022 revenues suggests growth of 26.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The same for earnings indicates an increase of 39.1{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s P/B ratio of 1.1 compares favorably with the industry’s 2.1.

Addus HomeCare: Addus HomeCare’s services and operating model address a number of crucial needs across the healthcare continuum. In October, the company announced its third-quarter 2022 results, where it registered a solid uptick in its net service revenues. Management confirmed that its personal care revenues (accounting for 74.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of overall revenue) improved on a same-store basis. For its home health business, Addus HomeCare achieved a robust organic growth rate in new admissions and total volumes on a same-store basis. ADUS carries a Zacks Rank of 3.

Price and Consensus: ADUS

Zacks Investment Research
Image Source: Zacks Investment Research

For this company, the Zacks Consensus Estimate for 2022 revenues suggests growth of 9.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s return on equity (ROE) of 8.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} compares favorably with the industry’s 5.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

Option Care Health: Option Care Health is a renowned independent provider of home and alternate site infusion services. In October, the company announced its third-quarter 2022 results, where it registered a solid uptick in its net revenues. At the time of the earnings release, Option Care Health confirmed that it has completed the acquisition of Rochester Home Infusion, Inc. OPCH carries a Zacks Rank of 3.

Price and Consensus: OPCH

Zacks Investment Research
Image Source: Zacks Investment Research

For this Bannockburn, IL-based company, the Zacks Consensus Estimate for 2022 revenues suggests growth of 14.6{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The same for earnings indicates an increase of 31.7{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s ROE of 11.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} compares favorably with the industry’s 5.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

The Pennant Group: The Pennant Group is the parent company of the Pennant group of affiliated home health, hospice and senior living companies. It reported its third-quarter 2022 results last month, where it witnessed solid improvement in its overall top line. Its Home Health and Hospice Services segment recorded a robust uptick in revenues, whereas the company also recorded strength in its total home health admissions and total Medicare home health admissions. The uptick in total hospice admissions and same-store senior living revenues for the third quarter was also impressive. PNTG carries a Zacks Rank of 3.

Price and Consensus: PNTG

Zacks Investment Research
Image Source: Zacks Investment Research

For this Eagle, ID-based company, the Zacks Consensus Estimate for 2022 revenues suggests growth of 5.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The same for earnings indicates an increase of 23.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s ROE of 9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} compares favorably with the industry’s 5.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in little more than 9 months and NVIDIA which boomed +175.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Option Care Health, Inc. (OPCH) : Free Stock Analysis Report

Addus HomeCare Corporation (ADUS) : Free Stock Analysis Report

The Pennant Group, Inc. (PNTG) : Free Stock Analysis Report

LifeStance Health Group, Inc. (LFST) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.